Table 2. Baseline characteristics of PL+ and PL- groups.
PL + | PL - | P value | |
---|---|---|---|
Number | 32 | 43 | |
Mean age ± SD (range) | 50±15.3 (19–78) | 51.2±14.6 (15–81) | 0.3 |
Male\Female N | 20\12 | 27\16 | 0.48 |
HTN N(%) | 13 (40.6) | 5 (11.6) | 0.033 |
T2-DM N(%) | 12 (37) | 12 (27.9) | 0.1 |
Hyperlipidemia N(%) | 7 (21.8) | 7 (16.3) | 0.2 |
Cirrhosis N(%) | 8 (25) | 8 (18.6) | 0.4 |
IHD N(%) | 7 (21.8) | 2 (4.6) | 0.06 |
Mean ALT (U/L) ± SD (range) | 51.3±45.4 (8–236) | 52.6 ±46.3 (8–226) | 0.45 |
Mean AST (U/L) ± SD (range) | 45.7±29.2 (15–137) | 50.9±50 (9–265) | 0.33 |
Mean GGT (U/L) ± SD (range) | 112.6±134.2 (16–618) | 96.5±78 (20–348) | 0.28 |
Mean ALK (U/L) ± SD (range) | 91.1±38.5 (45–201) | 108.3±96.5 (11–659) | 0.17 |
Mean T. Bili (umol/L) ± SD (range) | 20.3±25.7 (3–137) | 15.7±16.3 (3–84) | 0.17 |
Average NAS score (range) | 3.62 (1–6) | 2.74 (1–6) | 0.003 |
Average steatosis score (range) | 1.84 (1–3) | 1.6 (0–3) | 0.08 |
Average HB (range) | 1.06 (0–2) | 0.67 (0–2) | 0.008 |
Average LI (range) | 0.72 (0–2) | 0.46 (0–1) | 0.02 |
Average fibrosis (range) | 2.25 (0–4) | 1.53 (0–4) | 0.008 |
Average PI (range) | 1.12 (0–2) | 0.81 (0–2) | 0.008 |